Copyright
©The Author(s) 2023.
World J Clin Cases. Apr 6, 2023; 11(10): 2123-2139
Published online Apr 6, 2023. doi: 10.12998/wjcc.v11.i10.2123
Published online Apr 6, 2023. doi: 10.12998/wjcc.v11.i10.2123
Table 1 Coronary hyperemic agents
Agent | Dose | Side effects | |
Adenosine | Intravenous | 140 µg/kg/min IV; > 40 µg RCA; > 80 µg LCA | Transient AV block, chest pain, shortness of breath, hypotension, headache, flushing |
Intracoronary | |||
Regadenoson | 400 µg singe bolus central or peripheral IV | Rhythm or conduction abnormalities, rare gastrointestinal side effects, less frequent chest pain and dyspnea | |
Papaverine | 10-12 mg in RCA; 15-20 mg in LCA | Abdominal symptoms, headache, flushing of face, increase in heart rate, QTc prolongation, ventricular tachyarrhythmias |
- Citation: Boutaleb AM, Ghafari C, Ungureanu C, Carlier S. Fractional flow reserve and non-hyperemic indices: Essential tools for percutaneous coronary interventions. World J Clin Cases 2023; 11(10): 2123-2139
- URL: https://www.wjgnet.com/2307-8960/full/v11/i10/2123.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i10.2123